These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma. Glennie MJ; Brennand DM; Bryden F; McBride HM; Stirpe F; Worth AT; Stevenson GT J Immunol; 1988 Nov; 141(10):3662-70. PubMed ID: 3141503 [TBL] [Abstract][Full Text] [Related]
3. How to make bispecific antibodies. French RR Methods Mol Med; 2000; 40():333-9. PubMed ID: 21337104 [TBL] [Abstract][Full Text] [Related]
4. Bispecific F (ab')2 monomer prepared with anti-CD3 and anti-tumor monoclonal antibodies is most potent in induction of cytolysis of human T cells. Nitta T; Yagita H; Azuma T; Sato K; Okumura K Eur J Immunol; 1989 Aug; 19(8):1437-41. PubMed ID: 2528460 [TBL] [Abstract][Full Text] [Related]
5. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells. Tutt A; Stevenson GT; Glennie MJ J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655 [TBL] [Abstract][Full Text] [Related]
6. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Temponi M; Gold AM; Ferrone S Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670 [TBL] [Abstract][Full Text] [Related]
7. Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. Phillips NE; Parker DC J Immunol; 1984 Feb; 132(2):627-32. PubMed ID: 6228594 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells. Yamashita T; Koyama J J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734 [TBL] [Abstract][Full Text] [Related]
9. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo. French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599 [TBL] [Abstract][Full Text] [Related]
10. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies. Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin production by human peripheral lymphocytes induced by anti-C3 receptor antibodies. Daha MR; Bloem AC; Ballieux RE J Immunol; 1984 Mar; 132(3):1197-1201. PubMed ID: 6229578 [TBL] [Abstract][Full Text] [Related]
12. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies. Haegert DG Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876 [TBL] [Abstract][Full Text] [Related]
13. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus. Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758 [TBL] [Abstract][Full Text] [Related]
15. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability. Rodrigues ML; Snedecor B; Chen C; Wong WL; Garg S; Blank GS; Maneval D; Carter P J Immunol; 1993 Dec; 151(12):6954-61. PubMed ID: 7903100 [TBL] [Abstract][Full Text] [Related]
16. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Fan Z; Masui H; Altas I; Mendelsohn J Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of human monocyte activation via the 40-kDa Fc receptor for IgG. MacIntyre EA; Roberts PJ; Abdul-Gaffar R; O'Flynn K; Pilkington GR; Farace F; Morgan J; Linch DC J Immunol; 1988 Dec; 141(12):4333-43. PubMed ID: 2848894 [TBL] [Abstract][Full Text] [Related]
18. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies. Klaus GG; Bijsterbosch MK; Parkhouse RM Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110 [TBL] [Abstract][Full Text] [Related]
19. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation. Ledbetter JA; June CH; Martin PJ; Spooner CE; Hansen JA; Meier KE J Immunol; 1986 Jun; 136(11):3945-52. PubMed ID: 3084650 [TBL] [Abstract][Full Text] [Related]
20. Expression of immunoglobulin-cross-reactive molecules by neoplastic human T cells. I. Surface detection and isolation of molecules reactive with chicken anti-F(ab')2, anti-alpha and anti-mu antibodies. Haegert DG; Timm M Immunology; 1983 Nov; 50(3):447-59. PubMed ID: 6195097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]